Cargando…

Elimination of hepatitis C virus in Germany: modelling the cost-effectiveness of HCV screening strategies

BACKGROUND: Chronic hepatitis C is a major public health burden. With new interferon-free direct-acting agents (showing sustained viral response rates of more than 98%), elimination of HCV seems feasible for the first time. However, as HCV infection often remains undiagnosed, screening is crucial fo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krauth, Christian, Rossol, Siegbert, Ortsäter, Gustaf, Kautz, Achim, Krüger, Kathrin, Herder, Babette, Stahmeyer, Jona Theodor
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6889318/ https://www.ncbi.nlm.nih.gov/pubmed/31791253 http://dx.doi.org/10.1186/s12879-019-4524-z

Ejemplares similares

Cost-Effectiveness of Treating Hepatitis C with Sofosbuvir/Ledipasvir in Germany
por: Stahmeyer, Jona T., et al.
Publicado: (2017)

Lifestyle interventions for patients with non-alcoholic steato-hepatitis–Design, rationale and protocol of the study “target group-specific optimisation of lifestyle interventions for behavior change in non-alcoholic steato-hepatitis (OPTI-NASH)”
por: Krüger, Kathrin, et al.
Publicado: (2023)

Cost-effectiveness of Triple Therapy with Telaprevir for Chronic Hepatitis C Virus Patients in Germany
por: Stahmeyer, Jona T., et al.
Publicado: (2013)

Real‐world experience for the outcomes and costs of treating hepatitis C patients: Results from the German Hepatitis C-Registry (DHC-R)
por: Krüger, Kathrin, et al.
Publicado: (2022)

Non-Invasive Reliable Methods to Objectify the Positive Influence of Hepatitis C Virus Treatment on Liver Stiffness
por: Bert, Florian, et al.
Publicado: (2021)

Ultrasound Elastography Used for Preventive Non-Invasive Screening in Early Detection of Liver Fibrosis
por: Bert, Florian, et al.
Publicado: (2016)

Economic study of the value of expanding HCV treatment capacity in Germany
por: Sbarigia, Urbano, et al.
Publicado: (2017)

Outcomes and Costs of Treating Hepatitis C Patients in the Era of First Generation Protease Inhibitors – Results from the PAN Study
por: Stahmeyer, Jona T., et al.
Publicado: (2016)

Resource Utilisation and Costs of Depressive Patients in Germany: Results from the Primary Care Monitoring for Depressive Patients Trial
por: Krauth, Christian, et al.
Publicado: (2014)

Is there a place for sigmoidoscopy in colorectal cancer screening? A systematic review and critical appraisal of cost-effectiveness models
por: Diedrich, Leonie, et al.
Publicado: (2023)

Comparison of tools for assessing the methodological quality of primary and secondary studies in health technology assessment reports in Germany
por: Dreier, Maren, et al.
Publicado: (2010)

Willingness to provide informal care to older adults in Germany: a discrete choice experiment
por: de Jong, Lea, et al.
Publicado: (2022)

General populations’ preferences for colorectal cancer screening: rationale and protocol for the discrete choice experiment in the SIGMO study
por: Brinkmann, Melanie, et al.
Publicado: (2021)

Informal and formal care preferences and expected willingness of providing elderly care in Germany: protocol for a mixed-methods study
por: de Jong, Lea, et al.
Publicado: (2019)

Exploring the status of and demand for palliative day-care clinics and day hospices in Germany: a protocol for a mixed-methods study
por: Herbst, Franziska A., et al.
Publicado: (2021)

Willingness and preparedness to provide care: interviews with individuals of different ages and with different caregiving experiences
por: de Jong, Lea, et al.
Publicado: (2021)

Perspectives of hepatitis C virus (HCV) elimination in Poland
por: Flisiak, Robert, et al.
Publicado: (2019)

Quality indicators for the evaluation of end-of-life care in Germany – a retrospective cross-sectional analysis of statutory health insurance data
por: van Baal, Katharina, et al.
Publicado: (2020)

The effectiveness of additional screening examinations for children and adolescents in Germany: a longitudinal retrospective cohort study
por: Krüger, Kathrin, et al.
Publicado: (2023)

How is and how should healthcare for people with multiple sclerosis in Germany be designed?–The rationale and protocol for the mixed-methods study Multiple Sclerosis–Patient-Oriented Care in Lower Saxony (MS-PoV)
por: Krüger, Kathrin, et al.
Publicado: (2021)

Analysing the administration of an intermediate level of outpatient palliative care in Germany and developing recommendations for improvement (Polite): A study protocol for a mixed-methods study
por: Stiel, Stephanie, et al.
Publicado: (2021)

Hepatitis C virus screening in Piemonte: an effective strategy to eliminate HCV chronic infections
por: Thomas, R, et al.
Publicado: (2023)

Intersektorales Management von Patienten mit unklarer Leberwerterhöhung und nichtalkoholischer Fettlebererkrankung (NAFLD)
por: Teufel, Andreas, et al.
Publicado: (2023)

Impact of psychologically tailored hand hygiene interventions on nosocomial infections with multidrug-resistant organisms: results of the cluster-randomized controlled trial PSYGIENE
por: von Lengerke, Thomas, et al.
Publicado: (2019)

355. Barriers for Hepatitis C Elimination in HIV/HCV Coinfected Patients
por: Espinoza, Joe, et al.
Publicado: (2019)

Is HCV elimination possible in prison?
por: Crespo, J., et al.
Publicado: (2017)

Remaining challenges in HCV elimination
por: Capraru, Camelia, et al.
Publicado: (2021)

Progress toward implementing the Swiss Hepatitis Strategy: Is HCV elimination possible by 2030?
por: Müllhaupt, Beat, et al.
Publicado: (2018)

HCV hotline facilitates Hepatitis C elimination during the COVID‐19 pandemic
por: Hartl, Lukas, et al.
Publicado: (2022)

Claims Data Analysis on the Dispensing of Tricyclic Antidepressants Among Patients With Dementia in Germany
por: Hessmann, Philipp, et al.
Publicado: (2019)

Widening inequalities in multimorbidity? Time trends among the working population between 2005 and 2015 based on German health insurance data
por: Tetzlaff, Juliane, et al.
Publicado: (2018)

Elimination of HCV in Russia: Barriers and Perspective
por: Isakov, Vasily, et al.
Publicado: (2022)

The global campaign to eliminate HBV and HCV infection: International Viral Hepatitis Elimination Meeting and core indicators for development towards the 2030 elimination goals
por: Popping, Stephanie, et al.
Publicado: (2019)

Hepatitis C Virus Micro-Elimination Plan in Southern Italy: The “HCV ICEberg” Project
por: Coppola, Carmine, et al.
Publicado: (2023)

Determinants for participation in a prevention and early detection programme for children and adolescents in Germany: does social background play a role?
por: Krüger, Kathrin, et al.
Publicado: (2023)

HIV and HCV among drug users and people living in prisons in Germany 2022: WHO elimination targets as reflected in practice
por: Stöver, H., et al.
Publicado: (2023)

Effectiveness of Trainings of General Practitioners on Antibiotic Stewardship: Methods of a Pragmatic Quasi-Experimental Study in a Controlled Before-After Design in South-East-Lower Saxony, Germany (WASA)
por: Gornyk, Daniela, et al.
Publicado: (2021)

Implementation, barriers, and recommendations for further development of advance care planning for the last phase of life in nursing homes in Germany (Gut-Leben): protocol for a mixed-methods study
por: Stiel, Stephanie, et al.
Publicado: (2023)

Epidemiology and Elimination of HCV-Related Liver Disease
por: Pradat, Pierre, et al.
Publicado: (2018)

Eliminating HCV: a marathon, not a sprint
por: The Lancet Gastroenterology & Hepatology
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5hmdd5lh48lmqkh5q8vp632c2l